In 2015, Plaintiffs filed a First Amended Class Action Complaint on behalf of a proposed class of direct purchasers of branded and generic Namenda, a drug used to treat moderate-to-severe Alzheimer’s, alleging a two-pronged scheme on the part of Defendants to impair generic competition, including a “reverse payment” agreement to delay generic entry, and the […]
In 2017, Plaintiffs filed an Amended Complaint on behalf of a proposed class of indirect purchasers of Lovenox, and/or its generic equivalent enoxaparin, alleging an agreement among Defendants to monopolize sales of enoxaparin and prevent competition by controlling patented technology used to establish sameness for purposes of obtaining FDA approval to market generic enoxaparin. Counsel […]
In 2016, the Department of Labor (DOL) challenged a 2010 acquisition of the remaining 52% of shares of Sentry Equipment Erectors Inc. by its Employee Stock Ownership Plan (ESOP), claiming it overpaid in its $21 million purchase of the shares from company owner Adam Vinoskey, who was also an ESOP Trustee.
This year’s Global Investment Research Challenge is underway, including more than 5,700 participants from 1,100 universities worldwide. This annual event, which is sponsored globally by the CFA Institute and is hosted by local CFA chapters, saw the largest number of New York-area participants ever, with more than 30 university-sponsored teams submitting reports and presenting to […]
In the spirit of holiday giving, Monument Economics Group has again made donations to four local charities on behalf of its business partners: So Others Might Eat in Washington, DC; Robin Hood Foundation and Brain & Behavior Research Foundation in New York, NY; and Broad Street Ministry in Philadelphia, PA. All four organizations make a profound […]